Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

  • Read more about A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

  • Read more about "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)

  • Read more about Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)

A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

  • Read more about A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

Duke Street Bio Ltd

By jpalfreyman on Mon, 07/28/2025 - 09:58
  • Read more about Duke Street Bio Ltd

Neutralizing Power of Serum Antibodies - 2

  • Read more about Neutralizing Power of Serum Antibodies - 2

Efficacy and Safety of NVX-CoV2705

  • Read more about Efficacy and Safety of NVX-CoV2705

Zenith Epigenetics Ltd

By jpalfreyman on Fri, 07/25/2025 - 10:40
  • Read more about Zenith Epigenetics Ltd

Safety and Immunogenicity of NVX-CoV2705

  • Read more about Safety and Immunogenicity of NVX-CoV2705

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

  • Read more about Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Current page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA